4.5 Article

Translational Modeling Identifies Synergy between Nanoparticle-Delivered miRNA-22 and Standard-of-Care Drugs in Triple-Negative Breast Cancer

Related references

Note: Only part of the references are listed.
Review Oncology

Epidemiology of Triple-Negative Breast Cancer A Review

Frederick M. Howard et al.

Summary: Triple-negative breast cancer accounts for a significant portion of diagnoses in the United States, with lower survival rates compared to other breast cancer subtypes. Disparities exist in terms of ethnic and genetic risk factors, particularly affecting African American women and carriers of specific gene mutations. Integrating genomic predictors and epidemiological characteristics is essential for providing personalized care and addressing the disparities in outcomes for this deadly disease.

CANCER JOURNAL (2021)

Article Medicine, Research & Experimental

ncRNA therapy with miRNA-22-3p suppresses the growth of triple-negative breast cancer

Aysegul Gorur et al.

Summary: Deregulation of noncoding RNAs, specifically miR-22-3p, plays a significant role in the pathogenesis of triple-negative breast cancer (TNBC). Restoration of miR-22-3p expression inhibits TNBC cell proliferation, migration, and invasion by targeting eukaryotic elongation factor 2 kinase (eEF2K). Systemic administration of miR-22-3p in lipid nanoparticles effectively suppresses tumor growth in TNBC models, indicating its potential as a novel noncoding RNA-based therapy for TNBC.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Review Oncology

Checkpoint inhibitor therapy for metastatic triple-negative breast cancer

Arielle L. Heeke et al.

Summary: Immunotherapy has become a key component in the treatment of cancer, with promising activity observed in metastatic triple-negative breast cancer (TNBC) through PD-1/PD-L1 checkpoint inhibitor therapy. Accelerated approvals by the FDA for atezolizumab and pembrolizumab in 2019 and 2020, respectively, have provided hope for the treatment of PD-L1-positive TNBC.

CANCER AND METASTASIS REVIEWS (2021)

Article Chemistry, Medicinal

Innate Immunity Plays a Key Role in Controlling Viral Load in COVID-19: Mechanistic Insights from a Whole-Body Infection Dynamics Model

Prashant Dogra et al.

Summary: A multiscale mechanistic model was developed to simulate the time-dependent evolution of viral load distribution in susceptible organs of the body, guided by ACE2 receptor dependency of the virus. The model was used to study the effects of antiviral drug therapy and interferon therapy on viral load kinetics of SARS-CoV-2, revealing the dominant role of innate immunity in controlling viral load dynamics.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

Article Oncology

Calculating the Tumor Nuclei Content for Comprehensive Cancer Panel Testing

Masashi Mikubo et al.

JOURNAL OF THORACIC ONCOLOGY (2020)

Article Biochemistry & Molecular Biology

A mathematical model to predict nanomedicine pharmacokinetics and tumor delivery

Prashant Dogra et al.

COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2020)

Article Engineering, Biomedical

A Multiscale Agent-Based Model of Ductal Carcinoma In Situ

Joseph D. Butner et al.

IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING (2020)

Review Nanoscience & Nanotechnology

Image-guided mathematical modeling for pharmacological evaluation of nanomaterials and monoclonal antibodies

Prashant Dogra et al.

WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2020)

Article Oncology

Characterization of human cancer xenografts in humanized mice

Jonathan Rios-Doria et al.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)

Article Multidisciplinary Sciences

Sequential deconstruction of composite drug transport in metastatic breast cancer

Shreya Goel et al.

SCIENCE ADVANCES (2020)

Article Biochemistry & Molecular Biology

eEF2K enhances expression of PD-L1 by promoting the translation of its mRNA

Yu Wu et al.

BIOCHEMICAL JOURNAL (2020)

Article Chemistry, Physical

The dose threshold for nanoparticle tumour delivery

Ben Ouyang et al.

NATURE MATERIALS (2020)

Article Chemistry, Multidisciplinary

Intratumoral injection of hydrogel-embedded nanoparticles enhances retention in glioblastoma

Giulia Brachi et al.

NANOSCALE (2020)

Article Engineering, Biomedical

Mathematical modeling in cancer nanomedicine: a review

Prashant Dogra et al.

BIOMEDICAL MICRODEVICES (2019)

Review Chemistry, Multidisciplinary

MicroRNA delivery through nanoparticles

Sharon Wei Ling Lee et al.

JOURNAL OF CONTROLLED RELEASE (2019)

Article Multidisciplinary Sciences

Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles

Aldenor G. Santos et al.

SCIENTIFIC REPORTS (2019)

Article Oncology

Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort

Homero Goncalves et al.

CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2018)

Review Oncology

Eukaryotic Elongation Factor 2 Kinase (eEF2K) in Cancer

Xuemin Wang et al.

CANCERS (2017)

Article Biochemistry & Molecular Biology

Degradation dynamics of microRNAs revealed by a novel pulse-chase approach

Matteo J. Marzi et al.

GENOME RESEARCH (2016)

Review Biotechnology & Applied Microbiology

The effect of nanoparticle size on in vivo pharmacokinetics and cellular interaction

Nazanin Hoshyar et al.

NANOMEDICINE (2016)

Review Oncology

Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease

Giampaolo Bianchini et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2016)

Article Multidisciplinary Sciences

Integrated nanotechnology platform for tumor-targeted multimodal imaging and therapeutic cargo release

Hitomi Hosoya et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)

Article Biochemical Research Methods

Theory and Experimental Validation of a Spatio-temporal Model of Chemotherapy Transport to Enhance Tumor Cell Kill

Zhihui Wang et al.

PLOS COMPUTATIONAL BIOLOGY (2016)

Article Nanoscience & Nanotechnology

Analysis of nanoparticle delivery to tumours

Stefan Wilhelm et al.

NATURE REVIEWS MATERIALS (2016)

Article Multidisciplinary Sciences

Exosomal miRs in Lung Cancer: A Mathematical Model

Xiulan Lai et al.

PLOS ONE (2016)

Review Pharmacology & Pharmacy

Integrated PK-PD and agent-based modeling in oncology

Zhihui Wang et al.

JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS (2015)

Article Multidisciplinary Sciences

MicroRNA silencing for cancer therapy targeted to the tumour microenvironment

Christopher J. Cheng et al.

NATURE (2015)

Article Oncology

Understanding Drug Resistance in Breast Cancer with Mathematical Oncology

Terisse Brocato et al.

CURRENT BREAST CANCER REPORTS (2014)

Article Engineering, Biomedical

Cationic Nanoparticles Have Superior Transvascular Flux into Solid Tumors: Insights from a Mathematical Model

Triantafyllos Stylianopoulos et al.

ANNALS OF BIOMEDICAL ENGINEERING (2013)

Article Biology

Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation

Xiao-chun Wang et al.

JOURNAL OF RADIATION RESEARCH (2013)

Article Immunology

Matching cellular dimensions with molecular sizes

Michael Reth

NATURE IMMUNOLOGY (2013)

Article Multidisciplinary Sciences

A Mathematical Model for MicroRNA in Lung Cancer

Hye-Won Kang et al.

PLOS ONE (2013)

Article Biology

Identifying therapeutic targets in a combined EGFR-TGFβR signalling cascade using a multiscale agent-based cancer model

Zhihui Wang et al.

MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2012)

Article Biochemistry & Molecular Biology

Kinetic signatures of microRNA modes of action

Nadya Morozova et al.

Article Biochemistry & Molecular Biology

Control of EVI-1 oncogene expression in metastatic breast cancer cells through microRNA miR-22

J. B. Patel et al.

ONCOGENE (2011)

Review Oncology

The Promise of MicroRNA Replacement Therapy

Andreas G. Bader et al.

CANCER RESEARCH (2010)

Review Medicine, Research & Experimental

MicroRNAs in Cancer

Ramiro Garzon et al.

ANNUAL REVIEW OF MEDICINE (2009)

Article Biochemical Research Methods

Cross-scale, cross-pathway evaluation using an agent-based non-small cell lung cancer model

Zhihui Wang et al.

BIOINFORMATICS (2009)

Editorial Material Biochemistry & Molecular Biology

New Hope for a MicroRNA Therapy for Liver Cancer

John J. Rossi

Article Oncology

New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)

E. A. Eisenhauer et al.

EUROPEAN JOURNAL OF CANCER (2009)

Article Multidisciplinary Sciences

MicroRNA regulation of a cancer network: Consequences of the feedback loops involving miR-17-92, E2F, and Myc

Baltazar D. Aguda et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biotechnology & Applied Microbiology

Renal clearance of quantum dots

Hak Soo Choi et al.

NATURE BIOTECHNOLOGY (2007)

Review Oncology

MicroRNA-cancer connection: The beginning of a new tale

George Adrian Calin et al.

CANCER RESEARCH (2006)

Article Chemistry, Medicinal

Doxorubicin pharmacokinetics: Macromolecule binding, metabolism, and excretion in the context of a physiologic model

DL Gustafson et al.

JOURNAL OF PHARMACEUTICAL SCIENCES (2002)

Article Pathology

Openings between defective endothelial cells explain tumor vessel leakiness

H Hashizume et al.

AMERICAN JOURNAL OF PATHOLOGY (2000)